In general practice, waiting rooms are quiet, there are fewer locums, and, for now at least, the Care […]
Covid-19 has been a dramatic global health and economic shock. As SARS-CoV-2 spread across nations, economic activity plummeted, […]
US drug prices are the highest in the world and are continuing to rise, with an increasing number […]
History will remember 2020 as the year when the covid-19 pandemic plunged the world into turmoil, leaving climate […]
I, too, am deeply concerned about the secondary harms inflicted on patients and families by blanket restrictions.1 As […]
Updated Date: Wed, 30 Sep 2020 00:00:00 EDT
Twenty charities representing people affected by rare and less common cancers launch ’20 for 20′ campaign
Senior leaders from patient organisations and the pharma industry came together to discuss best practice in patient partnerships
New report finds UK is leading on early-stage clinical trials but needs strategy to restart non-COVID research
New agreement allows countries in the EU, EEA and the UK to purchase drug